Craft
Synspira

Synspira

Total Funding

$11.2 M

Synspira Summary

Company summary

Overview
Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases such as primary ciliary dyskinesia and bronchiectasis. It develops SNSP113, an inhaled non-absorbed glycopolymer therapeutics.
Type
Private
Founded
2017
HQ
Framingham, MA, US | view all locations
Website
https://www.synspira.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Framingham, MA HQ

    United States

    10 Speen St

Footer menu